Marketing-authorisation holder · Brazil

Bionovis S.A. - Companhia Brasileira de Biotecnologia Farmaceutica

Valinhos, BrazilRegistered 20108 medicines1 country

8 medicines in 1 country, as authorisation holder and manufacturer.

Medicines

Every medicine in the registers under its name, current ones first.

8 medicines

Medicine	Substance	Country	Status	Authorised
BEVANOVIS	Bevacizumab	Brazil	Authorised	2024
HERCULIZ	Eculizumab	Brazil	Authorised	2026
NOCLAR	Denosumab	Brazil	Authorised	2026
OPTINÓVIS	Ranibizumab	Brazil	Authorised	2025
PEGTIMA	Pegfilgrastim	Brazil	Authorised	2023
TUXYN	Rituximab	Brazil	Authorised	2025
XDENO	Denosumab	Brazil	Authorised	2026
HERCULIZ	Eculizumab	Brazil	Cancelled	2025

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Marketing-authorisation holder · Brazil

Bionovis S.A. - Companhia Brasileira de Biotecnologia Farmaceutica

Valinhos, BrazilRegistered 20108 medicines1 country

8 medicines in 1 country, as authorisation holder and manufacturer.

Its medicines

Medicines

Every medicine in the registers under its name, current ones first.

8 medicines

Medicine	Substance	Country	Status	Authorised
BEVANOVIS	Bevacizumab	Brazil	Authorised	2024
HERCULIZ	Eculizumab	Brazil	Authorised	2026
NOCLAR	Denosumab	Brazil	Authorised	2026
OPTINÓVIS	Ranibizumab	Brazil	Authorised	2025
PEGTIMA	Pegfilgrastim	Brazil	Authorised	2023
TUXYN	Rituximab	Brazil	Authorised	2025
XDENO	Denosumab	Brazil	Authorised	2026
HERCULIZ	Eculizumab	Brazil	Cancelled	2025

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Brazil	8	7	1	Companies All medicines

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

bionovis s a companhia brasileira de biotecnologia
bionovis s a companhia brasileira de biotecnologia farmaceutica

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

ANVISA / CMED

ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date

Licence: Other (Public Domain)

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Global Legal Entity Identifier Foundation

GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.

Licence: CC0

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Marketing-authorisation holder
Headquarters: Valinhos, Brazil
Registered: 15 Jul 2010
Status: Active
Medicines: 8
Countries: 1
Roles: Authorisation holder and manufacturer
Verified legal entity: Yes

Bionovis S.A. - Companhia Brasileira de Biotecnologia Farmaceutica

Medicines

Know your medicines, with the sources.

Bionovis S.A. - Companhia Brasileira de Biotecnologia Farmaceutica

Medicines

Know your medicines, with the sources.

Countries

Top substances

Names in the registers

Sources and licences

At a glance

Identifiers

Brazil: more companies